SARS-CoV-2 Testing
A real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene® instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens.
Catalog Number: 410700
Improve Efficiency, Deliver Standardization
- Near patient testing with Revogene® provides a rapid turnaround time which optimizes patient management by providing an earlier diagnosis for improved patient outcomes
- Revogene® can help infections from being transmitted to others through rapid execution of infection prevention strategies
- Revogene® provides clinicians with actionable results for faster treatment decisions
“CDC recommends that anyone with any signs or symptoms of COVID-19 get tested, regardless of vaccination status or prior infection.”
Support & Documents
Downloadable PDFs
FAQs
CPT Code 87635
Nasopharyngeal, anterior nasal, mid-turbinate nasal, or oropharyngeal swab specimens collected according to standard technique and placed in 3 mL of transport media according to manufacturer’s instructions.
Swab specimens collected in VTM/UTM can be stored at 2-8 C for up to seven (7) days before being tested with the Revogene SARS-CoV-2 assay. Specimens collected in CDC media, MicroTest™ M4RT® (Remel), or saline may be stored up to 72 hours at 2-8 C before use.
The Revogene SARS-CoV-2 kit can be stored at 2-8 C. The expiration date is indicated on the kit box label. For more information, please refer to the Revogene SARS-CoV-2 package insert.
Get In Touch With A Specialist
